CPRX Q1 2019 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

CPRXCatalyst Pharmaceuticals, Inc.

$3B

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$12M

Gross Profit

$11M86.2% margin

Operating Income

-$987,769-7.9% margin

Net Income

-$644,503-5.2% margin

EPS (Diluted)

$-0.01

QoQ Revenue Growth

+2389.7%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$933,411

Balance Sheet

Total Assets

$61M

Total Liabilities

$10M

Stockholders' Equity

$51M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$0	—
Gross Profit	$11M	-$3M	+429.4%
Operating Income	-$987,769	-$6M	+83.4%
Net Income	-$644,503	-$6M	+88.7%